CLINICAL_TRIALS
research
· 2025-05-22
Clinical Trial Update: Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly [NA]
Summary
An ongoing clinical trial is evaluating dose-adjusted chemoradiotherapy for HPV-associated oropharyngeal cancer in elderly patients with frailty, and it is curr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Omar Mahmoud | Conditions: Oropharynx Cancer, Frailty | NA | Status: RECRUITING